Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters











Publication year range
1.
J Pediatr ; 271: 114050, 2024 Aug.
Article in English | MEDLINE | ID: mdl-38641165

ABSTRACT

OBJECTIVE: To evaluate associations between change in weight z score after neonatal intensive care unit (NICU) discharge and neurodevelopmental outcomes and obesity at 12-48 months of age among individuals born very preterm. STUDY DESIGN: This secondary analysis used data from infants born very preterm participating in the Environmental influences on Child Health Outcomes cohort (n = 1400). Growth during infancy was calculated as change in weight z score between NICU discharge and follow-up at a mean of 27 months of age. Very low weight gain was defined as a change in weight z score <-1.67; very high weight gain was a change in weight z score >1.67. Neurodevelopmental outcomes included the Bayley Scales of Infant and Toddler Development, Child Behavior Checklist 1.5-5 years, and Modified Checklist for Autism in Toddlers. Multivariable linear regression was used to estimate associations between increase in weight z score and neurodevelopmental outcomes. RESULTS: Very low weight gain between NICU discharge and follow-up (experienced by 6.4% of participants) was associated with lower scores on cognitive (adjusted mean difference: -4.26; 95% CI: -8.55, -0.04) and language (adjusted mean difference: -4.80; 95% CI: -9.70, -0.11) assessments. Very high weight gain (experienced by 13.6% of participants) was associated with an increased obesity risk (adjusted relative risk: 6.20; 95% CI: 3.99, 9.66) but not with neurodevelopmental outcomes. CONCLUSIONS: Very high weight gain in the first 12-48 months after NICU discharge was associated with a higher risk of obesity at follow-up; very low weight gain was associated with lower scores on cognitive and language assessments.


Subject(s)
Child Development , Weight Gain , Humans , Male , Female , Infant , Child, Preschool , Infant, Newborn , Child Development/physiology , Pediatric Obesity/epidemiology , Infant, Extremely Premature/growth & development , Intensive Care Units, Neonatal , Cohort Studies , Follow-Up Studies , Neurodevelopmental Disorders/epidemiology , Neurodevelopmental Disorders/etiology
2.
J Pediatr ; 260: 113468, 2023 09.
Article in English | MEDLINE | ID: mdl-37182662

ABSTRACT

OBJECTIVES: To predict behavioral disruptions in middle childhood, we identified latent classes of prenatal substance use. STUDY DESIGN: As part of the Environmental influences on Child Health Outcomes Program, we harmonized prenatal substance use data and child behavior outcomes from 2195 women and their 6- to 11-year-old children across 10 cohorts in the US and used latent class-adjusted regression models to predict parent-rated child behavior. RESULTS: Three latent classes fit the data: low use (90.5%; n = 1986), primarily using no substances; licit use (6.6%; n = 145), mainly using nicotine with a moderate likelihood of using alcohol and marijuana; and illicit use (2.9%; n = 64), predominantly using illicit substances along with a moderate likelihood of using licit substances. Children exposed to primarily licit substances in utero had greater levels of externalizing behavior than children exposed to low or no substances (P = .001, d = .64). Children exposed to illicit substances in utero showed small but significant elevations in internalizing behavior than children exposed to low or no substances (P < .001, d = .16). CONCLUSIONS: The differences in prenatal polysubstance use may increase risk for specific childhood problem behaviors; however, child outcomes appeared comparably adverse for both licit and illicit polysubstance exposure. We highlight the need for similar multicohort, large-scale studies to examine childhood outcomes based on prenatal substance use profiles.


Subject(s)
Child Behavior Disorders , Prenatal Exposure Delayed Effects , Problem Behavior , Substance-Related Disorders , Pregnancy , Humans , Child , Female , Latent Class Analysis , Substance-Related Disorders/epidemiology , Child Behavior , Child Behavior Disorders/epidemiology , Child Behavior Disorders/etiology , Prenatal Exposure Delayed Effects/epidemiology
3.
J Pediatr ; 230: 23-31.e10, 2021 03.
Article in English | MEDLINE | ID: mdl-33197493

ABSTRACT

OBJECTIVE: To characterize the demographic and clinical features of pediatric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) syndromes and identify admission variables predictive of disease severity. STUDY DESIGN: We conducted a multicenter, retrospective, and prospective study of pediatric patients hospitalized with acute SARS-CoV-2 infections and multisystem inflammatory syndrome in children (MIS-C) at 8 sites in New York, New Jersey, and Connecticut. RESULTS: We identified 281 hospitalized patients with SARS-CoV-2 infections and divided them into 3 groups based on clinical features. Overall, 143 (51%) had respiratory disease, 69 (25%) had MIS-C, and 69 (25%) had other manifestations including gastrointestinal illness or fever. Patients with MIS-C were more likely to identify as non-Hispanic black compared with patients with respiratory disease (35% vs 18%, P = .02). Seven patients (2%) died and 114 (41%) were admitted to the intensive care unit. In multivariable analyses, obesity (OR 3.39, 95% CI 1.26-9.10, P = .02) and hypoxia on admission (OR 4.01; 95% CI 1.14-14.15; P = .03) were predictive of severe respiratory disease. Lower absolute lymphocyte count (OR 8.33 per unit decrease in 109 cells/L, 95% CI 2.32-33.33, P = .001) and greater C-reactive protein (OR 1.06 per unit increase in mg/dL, 95% CI 1.01-1.12, P = .017) were predictive of severe MIS-C. Race/ethnicity or socioeconomic status were not predictive of disease severity. CONCLUSIONS: We identified variables at the time of hospitalization that may help predict the development of severe SARS-CoV-2 disease manifestations in children and youth. These variables may have implications for future prognostic tools that inform hospital admission and clinical management.


Subject(s)
COVID-19/epidemiology , Hospitalization , Severity of Illness Index , Systemic Inflammatory Response Syndrome/epidemiology , Adolescent , Biomarkers/analysis , C-Reactive Protein/analysis , COVID-19/blood , Child , Child, Preschool , Connecticut/epidemiology , Female , Humans , Hypoxia/epidemiology , Infant , Intensive Care Units , Lymphocyte Count , Male , Multivariate Analysis , New Jersey/epidemiology , New York/epidemiology , Pediatric Obesity/epidemiology , Procalcitonin/blood , Prospective Studies , Retrospective Studies , Systemic Inflammatory Response Syndrome/blood , Troponin/blood , Young Adult
4.
J Pediatr ; 198: 162-167, 2018 07.
Article in English | MEDLINE | ID: mdl-29703576

ABSTRACT

OBJECTIVE: To examine the effect of heart rate characteristics (HRC) monitoring on length of stay among very low birth weight (VLBW; <1500 g birth weight) neonates in the HeRO randomized controlled trial (RCT). STUDY DESIGN: We performed a retrospective analysis of length of stay metrics among 3 subpopulations (all patients, all survivors, and survivors with positive blood or urine cultures) enrolled in a multicenter, RCT of HRC monitoring. RESULTS: Among all patients in the RCT, infants randomized to receive HRC monitoring were more likely than controls to be discharged alive and prior to day 120 (83.6% vs 80.1%, P = .014). The postmenstrual age at discharge for survivors with positive blood or urine cultures was 3.2 days lower among infants randomized to receive HRC monitoring when compared with controls (P = .026). Although there were trends in other metrics toward reduced length of stay in HRC-monitored patients, none reached statistical significance. CONCLUSIONS: HRC monitoring is associated with reduced mortality in VLBW patients and a reduction in length of stay among infected surviving VLBW infants. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00307333.


Subject(s)
Heart Rate Determination , Heart Rate/physiology , Intensive Care Units, Neonatal , Length of Stay , Female , Humans , Infant, Newborn , Infant, Very Low Birth Weight , Male , Patient Discharge , Retrospective Studies
5.
J Pediatr ; 197: 280-285.e3, 2018 06.
Article in English | MEDLINE | ID: mdl-29398053

ABSTRACT

We examined the effect of maternal smoking on plasma and urinary levels of vitamin E isoforms in preterm infants. Maternal smoking during pregnancy decreased infant plasma alpha- and gamma-tocopherol concentrations at 1 week and 4 weeks, with 45% of infants of smokers deficient in alpha-tocopherol at 1 month after birth.


Subject(s)
Infant, Extremely Premature/metabolism , Prenatal Exposure Delayed Effects/metabolism , Smoking/adverse effects , Vitamin E/metabolism , Adult , Biomarkers/metabolism , Female , Humans , Infant, Newborn , Male , Oxidative Stress/physiology , Pregnancy , Prospective Studies , Risk Factors
11.
J Pediatr ; 159(6): 900-6.e1, 2011 Dec.
Article in English | MEDLINE | ID: mdl-21864846

ABSTRACT

OBJECTIVE: To test the hypothesis that heart rate characteristics (HRC) monitoring improves neonatal outcomes. STUDY DESIGN: We conducted a two-group, parallel, individually randomized controlled clinical trial of 3003 very low birth weight infants in 9 neonatal intensive care units. In one group, HRC monitoring was displayed; in the other, it was masked. The primary outcome was number of days alive and ventilator-free in the 120 days after randomization. Secondary outcomes were mortality, number of ventilator days, neonatal intensive care unit stay, and antibiotic use. RESULTS: The mortality rate was reduced in infants whose HRC monitoring was displayed, from 10.2% to 8.1% (hazard ratio, 0.78; 95% CI, 0.61-0.99; P = .04; number needed to monitor = 48), and there was a trend toward increased days alive and ventilator-free (95.9 of 120 days compared with 93.6 in control subjects, P = .08). The mortality benefit was concentrated in infants with a birth weight <1000 g (hazard ratio, 0.74; 95% CI, 0.57-0.95; P = .02; number needed to monitor = 23). There were no significant differences in the other outcomes. CONCLUSION: HRC monitoring can reduce the mortality rate in very low birth weight infants.


Subject(s)
Heart Rate , Infant, Newborn, Diseases/mortality , Infant, Newborn, Diseases/physiopathology , Infant, Very Low Birth Weight , Monitoring, Physiologic , Female , Humans , Infant, Newborn , Male
SELECTION OF CITATIONS
SEARCH DETAIL